Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer

PURPOSE: The recent publication of the ACOSOG Z1031 trial results demonstrated that Ki-67 proliferation marker-based neoadjuvant endocrine therapy response monitoring could be used for tailoring the use of adjuvant chemotherapy in ER+HER2-negative breast cancer patients. In this paper, we describe t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Breast Cancer Res Treat
Egile Nagusiak: Goncalves, Rodrigo, DeSchryver, Katherine, Ma, Cynthia, Tao, Yu, Hoog, Jeremy, Cheang, Maggie, Crouch, Erika, Dahiya, Neha, Sanati, Souzan, Barnes, Michael, Sarian, Luis Otávio Zanatta, Olson, John, Allred, Donald Craig, Ellis, Matthew J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer US 2017
Gaiak:
Clinical Trial
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5543203/
https://ncbi.nlm.nih.gov/pubmed/28612227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4329-y
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak